Jamilee Cathy Seavey, OTR | |
209 Moller Ave Ste 100, Sitka, AK 99835-7142 | |
(907) 747-1771 | |
(907) 747-8853 |
Full Name | Jamilee Cathy Seavey |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 209 Moller Ave Ste 100, Sitka, Alaska |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1194069385 | NPI | - | NPPES |
114425 | Other | AK | STATE OF ALASKA |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 113680 (Texas) | Primary |
Provider Name | Southeast Alaska Regional Health Consortium |
---|---|
Provider Type | Part B Supplier - Clinic/group Practice |
Provider Identifiers | NPI Number: 1376758037 PECOS PAC ID: 1456265362 Enrollment ID: O20031114000631 |
News Archive
Meeting new people can be both stressful and rewarding. Research at the Max Planck Institute of Psychiatry, reported today in Nature Neuroscience, suggests that a molecule involved in regulating stress in the brain may also help determine how willing we are to leave the safety of our social group and strike up new relationships.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, has filed a request with the U.S. Food and Drug Administration for designation of its lead product candidate, Neutrolin Catheter Lock Solution, as a qualified infectious disease product (QIDP) pursuant to the Generating Antibiotic Incentives Now (GAIN) title of the Food and Drug Administration Safety and Innovation Act.
New connections between brain cells emerge in clusters in the brain as animals learn to perform a new task, according to a study published in Nature on February 19 (advance online publication). Led by researchers at the University of California, Santa Cruz, the study reveals details of how brain circuits are rewired during the formation of new motor memories.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
Patients with longer-lasting chest pain are more likely having a heart attack than those with pain of a shorter duration, according to a study by researchers at Henry Ford Hospital.
› Verified 7 days ago
Mailing Address | Practice Location Address |
---|---|
Jamilee Cathy Seavey, OTR 3100 Channel Dr Ste 300, Juneau, AK 99801-7837 Ph: (907) 463-4074 | Jamilee Cathy Seavey, OTR 209 Moller Ave Ste 100, Sitka, AK 99835-7142 Ph: (907) 747-1771 |
News Archive
Meeting new people can be both stressful and rewarding. Research at the Max Planck Institute of Psychiatry, reported today in Nature Neuroscience, suggests that a molecule involved in regulating stress in the brain may also help determine how willing we are to leave the safety of our social group and strike up new relationships.
CorMedix Inc., a pharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of cardiac, renal and infectious disease, has filed a request with the U.S. Food and Drug Administration for designation of its lead product candidate, Neutrolin Catheter Lock Solution, as a qualified infectious disease product (QIDP) pursuant to the Generating Antibiotic Incentives Now (GAIN) title of the Food and Drug Administration Safety and Innovation Act.
New connections between brain cells emerge in clusters in the brain as animals learn to perform a new task, according to a study published in Nature on February 19 (advance online publication). Led by researchers at the University of California, Santa Cruz, the study reveals details of how brain circuits are rewired during the formation of new motor memories.
CardioVascular BioTherapeutics, Inc. , announced today that it has dosed the first patient in North America (NA) as part of its ACORD Phase II clinical trial to treat patients with severe coronary heart disease.
Patients with longer-lasting chest pain are more likely having a heart attack than those with pain of a shorter duration, according to a study by researchers at Henry Ford Hospital.
› Verified 7 days ago
Mrs. Mari-margaret Celeste Tydingco, OT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 118 Jacobs Cir, Sitka, AK 99835 Phone: 907-738-0923 | |
Kari Janece Defreest, OTR/L, CHT Occupational Therapist Medicare: Medicare Enrolled Practice Location: 222 Tongass Dr, Sitka, AK 99835 Phone: 907-966-2411 | |
Ms. Lois Joanne Verbaan, OTR Occupational Therapist Medicare: May Accept Medicare Assignments Practice Location: 1301 Edgecumbe Dr, Sitka, AK 99835 Phone: 907-752-8264 | |
Charlotte Kimber, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1803 Edgecumbe Dr, Sitka, AK 99835 Phone: 907-738-1008 | |
Miss Keri Jo Mcentee, MS, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 209 Moller Ave Ste 102, Sitka, AK 99835 Phone: 907-966-8969 | |
Victoria Agnes Hay, OT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 222 Tongass Dr, Sitka, AK 99835 Phone: 907-966-2411 Fax: 907-966-8606 |